Circulation June 2022 PMID 35603667

Estimating the Benefits of Combination Medical Therapy in Heart Failure With Mildly Reduced and Preserved Ejection Fraction.

Muthiah Vaduganathan, Brian L Claggett, Riccardo M Inciardi, Gregg C Fonarow, John J V McMurray, Scott D Solomon

Download social card

Mentions

171

Peak: 89 in May 2022

across 3 sources since May 2022

Extended reach

683,338

potential audience

Total likes

359

Video views

3,405

Mentions per month

May 2022 – May 2024

Where it's discussed

X / Twitter167 posts
YouTube2 videos
Facebook2 posts

AI synopsis

What people are saying

The social discussions uniformly show strong support for the article, with posts describing the potential of combination treatments like ARNI, MRA, and SGLT2i to significantly improve outcomes in heart failure patients. The tone is enthusiastic and considers the findings as a promising step toward optimizing therapy, indicating deep engagement and potential influence on clinical practice.

AgreementStrong agreement

Most discussions endorse the positive implications of the study, emphasizing the benefits of combination therapy for heart failure, indicating strong consensus.

InterestHigh interest

Posts consistently express high curiosity and highlight the importance of this research, showing strong engagement with the topic.

EngagementHigh engagement

Many discussions reference specific therapies (ARNI, MRA, SGLT2i) and emphasize implications for clinical practice, demonstrating deep involvement.

ImpactHigh impact

The discussions suggest the study could influence future treatment guidelines and stimulate further research, reflecting a high potential impact.

Abstract in brief

It analyzes the effectiveness of combining different medical treatments for patients with heart failure who have mildly reduced or preserved ejection fraction.
The study aims to quantify the potential benefits of this combination therapy in improving patient outcomes.
Findings may suggest new approaches for managing heart failure, guiding healthcare providers in treatment decisions.

Read the full abstract

All mentions

2022 Guidelines for Managing Heart Failure with Preserved Ejection Fraction

The 2022 AHA/ACC/HFSA Guideline for Heart Failure updates recommendations to improve patient-centered care. This video discusses the latest evidence-based practices and emphasizes aligning treatments with patient…

Cardioflash College · Aug 1, 2023 2,985 views

2022 Guidelines for Heart Failure Management Explained

This video discusses the 2022 AHA/ACC/HFSA guidelines for heart failure management, emphasizing improvements in patient-centered care. It reviews evidence-based practices and new recommendations that align treatments…

Cardioflash College · Aug 1, 2023 420 views

Rene

@Rene170295 · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 7, 2024 · 42 shares · 1 followers View post →

Andreas Gevaert

@AndreasGevaert · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 7, 2024 · 20 shares · 4,707 followers View post →

Yoga Yudhistira

@yudhistirayoga_ · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 7, 2024 · 20 shares · 25 followers View post →

Hiroyuki Sato 佐藤宏行

@foreverhero0819 · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 7, 2024 · 20 shares · 3,794 followers View post →

Jan Verwerft

@VerwerftJan · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 7, 2024 · 20 shares · 4,229 followers View post →

Philipp Lopatka

@LopatkaPhilipp · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 3, 2024 · 20 shares · 198 followers View post →

Jamie Wang

@jamiewang1228 · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 3, 2024 · 20 shares · 9 followers View post →

Paramvir Chauhan MD

@paramvir_dr · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 3, 2024 · 20 shares · 315 followers View post →

Bookdasa

@Totoro19514032 · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 3, 2024 · 20 shares · 11 followers View post →

Ana Vergés

@VergesAna · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 3, 2024 · 20 shares · 424 followers View post →

Seigo Izumo

@SeigoIzumo · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 2, 2024 · 20 shares · 3,967 followers View post →

Abdallah Al-Mohammad

@AAlMohammad87 · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 2, 2024 · 20 shares · 927 followers View post →

Juan Pedro Romero

@JuanPedroRome20 · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 2, 2024 · 20 shares · 204 followers View post →

EOLO MORANDI JR.

@eolojr · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 2, 2024 · 20 shares · 540 followers View post →

Peder L. Myhre MD, PhD

@pmyhre · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 2, 2024 · 20 shares · 1,483 followers View post →

maldinilin

@maldinilin · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 2, 2024 · 20 shares · 96 followers View post →

Muthu Vaduganathan

@mvaduganathan · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 2, 2024 · 20 shares · 9,160 followers View post →

Ivan Stankovic

@Ivan_Echocardio · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 2, 2024 · 20 shares · 6,120 followers View post →

Natsir Ramadhan

@natsiradhan · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 2, 2024 · 20 shares · 559 followers View post →

lal0155

@lal0155 · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 2, 2024 · 20 shares · 12 followers View post →

أ.د خالد فايز الحبيب

@KhalidFAlhabib · X

RT @gcfmd: “Benefit was largely explained by the triple combination of ARNI, MRA, and SGLT2i (HR: 0.56 [95% CI 0.43-0.71])” ARNI+MRA+SGLT2…

Apr 2, 2024 · 20 shares · 16,767 followers View post →

Gregg Fonarow MD

@gcfmd · X

Apr 2, 2024 · 49 likes · 20 shares · 11,826 followers View post →

Gregg Fonarow MD

@gcfmd · X

@MarkBelkinMD @HFpEF @JonathanDavisHF @NEJM @ValleAlfonso @UCSFIMChiefs https://t.co/WkCB5Iofma

Aug 25, 2023 · 4 likes · 11,826 followers View post →

Miriam Sandín

@miriamsandin · X

RT @JuliaSellerm: 4️⃣ Combinaciones farmacológicas

Dec 23, 2022 · 4 shares · 3,009 followers View post →

IThAnDeMoJi

@DraIthaMoreJ · X

RT @JuliaSellerm: 4️⃣ Combinaciones farmacológicas

Dec 23, 2022 · 4 shares · 84 followers View post →

Linda

@wordfinga · X

RT @JuliaSellerm: 4️⃣ Combinaciones farmacológicas

Dec 22, 2022 · 4 shares · 4,593 followers View post →

Juan Carlos Obaya

@jcobaya69 · X

RT @JuliaSellerm: 4️⃣ Combinaciones farmacológicas

Dec 21, 2022 · 4 shares · 857 followers View post →

Julia Seller

@JuliaSellerm · X

4️⃣ Combinaciones farmacológicas

Dec 21, 2022 · 15 likes · 4 shares · 6,010 followers View post →

Alejandro Mariño

@marinoalejo · X

Estimating the Benefits of Combination Medical Therapy in Heart Failure With Mildly Reduced and Preserved Ejection Fraction https://t.co/JFtMIOaq4Q https://t.co/fMqmAq3t1h

Sep 1, 2022 · 1 like · 469 followers View post →

Andrew J Sauer MD

@AndrewJSauer · X

RT @gcfmd: @2inspire4more @ASarkarMD @AndrewJSauer Estimating the Benefits of Combination Medical Therapy in Heart Failure With Mildly Redu…

Aug 24, 2022 · 1 share · 19,287 followers View post →

Gregg Fonarow MD

@gcfmd · X

@2inspire4more @ASarkarMD @AndrewJSauer Estimating the Benefits of Combination Medical Therapy in Heart Failure With Mildly Reduced and Preserved Ejection Fraction https://t.co/vht5c5Zb9Y

Aug 24, 2022 · 3 likes · 1 share · 11,826 followers View post →

Shankar Kumar

@kumarshankar88 · X

RT @mi_cardiologo: Efecto de la terapia combinada (ARNI+iSLGT2+AMR) en el pronostico de los pacientes con IC según la Fracción de eyección.…

Jul 5, 2022 · 37 shares · 639 followers View post →

Shankar Kumar

@kumarshankar88 · X

RT @hmkyale: @JWatch I thought this was an imp paper; it estimates benefits of combination therapy in #heartfailure using current data whil…

Jul 5, 2022 · 6 shares · 639 followers View post →

Alosa Health

@AlosaHealth · X

Combination treatment with mineralcorticoid receptor antagonists, ARNI, and SGLT2 inhibitors for patients with HF & LVEF 45-64% is associated with meaningful clinical benefit @mvaduganathan @gcfmd @UoGHeartFailure @scottdsolomon @CircAHA https://t.co/gWJMdp2oiE

Jun 23, 2022 · 4 likes · 1 share · 253 followers View post →

Lorenzo Bertomeu

@BertomeuLorenzo · X

RT @gt_hta: Hoy

Jun 22, 2022 · 7 shares · 1,409 followers View post →

Miguel Turégano

@tureyedro · X

RT @muriejo: Estimating the Benefits of Combination Medical Therapy in Heart Failure With Mildly Reduced and Preserved Ejection Fraction ht…

Jun 15, 2022 · 1 share · 811 followers View post →

Arnel Carmona

@ecgrhythms · X

RT @gcfmd: @JonathanDavisHF @mvaduganathan @JavedButler1 @NMHheartdoc Happy to 30 day and 1 year outcomes by EF https://t.co/iwIePO4b0Y…

Jun 15, 2022 · 3 shares · 27,647 followers View post →

Jose Carlos Muriel

@muriejo · X

Estimating the Benefits of Combination Medical Therapy in Heart Failure With Mildly Reduced and Preserved Ejection Fraction https://t.co/5lIkiSqk9L

Jun 13, 2022 · 3 likes · 1 share · 58 followers View post →

Amin Yehya, MD, MS, FACC, FHFSA

@AminYehyaMD · X

RT @gcfmd: @JonathanDavisHF @mvaduganathan @JavedButler1 @NMHheartdoc Happy to 30 day and 1 year outcomes by EF https://t.co/iwIePO4b0Y…

Jun 10, 2022 · 3 shares · 2,108 followers View post →

Manu Morales Sánchez

@Manugrillo2 · X

RT @hilariobad59: Estimating the Benefits of Combination Medical Therapy in Heart Failure With Mildly Reduced and Preserved Ejection Fracti…

Jun 10, 2022 · 1 share · 2,140 followers View post →

Hilario Badiola

@hilariobad59 · X

Estimating the Benefits of Combination Medical Therapy in Heart Failure With Mildly Reduced and Preserved Ejection Fraction https://t.co/xFG6zsgoEW (2/2)

Jun 10, 2022 · 1 share · 187 followers View post →

Juan Carlos Obaya

@jcobaya69 · X

RT @primastcar:

Jun 10, 2022 · 2 shares · 857 followers View post →

Primastcar

@primastcar · X

Jun 10, 2022 · 2 likes · 2 shares · 2,338 followers View post →

Hiroyuki Sato 佐藤宏行

@foreverhero0819 · X

RT @CircAHA: #ResearchLetter: Magnitude of benefit of combination therapy (MRA/ARNI/SGLT2i) in patients with HF with mildly reduced LVEF (4…

Jun 9, 2022 · 24 shares · 3,794 followers View post →

Sebastian Rosch

@RoschSeb · X

RT @CircAHA: #ResearchLetter: Magnitude of benefit of combination therapy (MRA/ARNI/SGLT2i) in patients with HF with mildly reduced LVEF (4…

Jun 9, 2022 · 24 shares · 200 followers View post →

Nicolas Renna, MD PhD ISHF FESC

@nicolasrennamd · X

RT @CircAHA: #ResearchLetter: Magnitude of benefit of combination therapy (MRA/ARNI/SGLT2i) in patients with HF with mildly reduced LVEF (4…

Jun 9, 2022 · 24 shares · 934 followers View post →

Daisuke Kamimura

@Daisukekmmr · X

RT @CircAHA: #ResearchLetter: Magnitude of benefit of combination therapy (MRA/ARNI/SGLT2i) in patients with HF with mildly reduced LVEF (4…

Jun 9, 2022 · 24 shares · 233 followers View post →

Wei Chen

@WeiChenKidney · X

RT @CircAHA: #ResearchLetter: Magnitude of benefit of combination therapy (MRA/ARNI/SGLT2i) in patients with HF with mildly reduced LVEF (4…

Jun 9, 2022 · 24 shares · 445 followers View post →

Akihiro Nomura

@akihiro_nomuryn · X

RT @CircAHA: #ResearchLetter: Magnitude of benefit of combination therapy (MRA/ARNI/SGLT2i) in patients with HF with mildly reduced LVEF (4…

Jun 9, 2022 · 24 shares · 1,899 followers View post →

Rodrigo Tapia Castro

@rodrigotapiac · X

RT @CircAHA: #ResearchLetter: Magnitude of benefit of combination therapy (MRA/ARNI/SGLT2i) in patients with HF with mildly reduced LVEF (4…

Jun 9, 2022 · 24 shares · 64 followers View post →

cardio Roland

@CardioRoland · X

RT @CircAHA: #ResearchLetter: Magnitude of benefit of combination therapy (MRA/ARNI/SGLT2i) in patients with HF with mildly reduced LVEF (4…

Jun 9, 2022 · 24 shares · 270 followers View post →

Juan Carlos Obaya

@jcobaya69 · X

RT @CircAHA: #ResearchLetter: Magnitude of benefit of combination therapy (MRA/ARNI/SGLT2i) in patients with HF with mildly reduced LVEF (4…

Jun 9, 2022 · 24 shares · 857 followers View post →

Muthu Vaduganathan

@mvaduganathan · X

RT @CircAHA: #ResearchLetter: Magnitude of benefit of combination therapy (MRA/ARNI/SGLT2i) in patients with HF with mildly reduced LVEF (4…

Jun 9, 2022 · 24 shares · 9,160 followers View post →

Circulation

@CircAHA · X

Jun 9, 2022 · 70 likes · 24 shares · 77,377 followers View post →

Anju Bhardwaj MD FACC

@docbhardwaj · X

RT @gcfmd: @JonathanDavisHF @mvaduganathan @JavedButler1 @NMHheartdoc Happy to 30 day and 1 year outcomes by EF https://t.co/iwIePO4b0Y…

Jun 9, 2022 · 3 shares · 4,521 followers View post →

Gregg Fonarow MD

@gcfmd · X

Jun 9, 2022 · 13 likes · 3 shares · 11,826 followers View post →

Carles Díez

@diez_carles · X

@JuliaSellerm https://t.co/A34BpkB3u2

Jun 8, 2022 · 2 likes · 752 followers View post →

Lorenzo Bertomeu

@BertomeuLorenzo · X

RT @mi_cardiologo: Efecto de la terapia combinada (ARNI+iSLGT2+AMR) en el pronostico de los pacientes con IC según la Fracción de eyección.…

Jun 8, 2022 · 37 shares · 1,409 followers View post →

José Luis Añorga Ocmin, MD

@Joseluis_MD29 · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

Jun 7, 2022 · 42 shares · 346 followers View post →

Paloma Cerezo

@cerezo_paloma · X

RT @gt_hta: Hoy

Jun 5, 2022 · 7 shares · 160 followers View post →

Lorenzo Bertomeu

@BertomeuLorenzo · X

RT @gt_hta: Hoy

Jun 5, 2022 · 7 shares · 1,409 followers View post →

Manuel Portela Romero

@DocMPortela · X

RT @gt_hta: Hoy

Jun 4, 2022 · 7 shares · 661 followers View post →

Teresa Gijon Conde

@TGijonConde · X

RT @gt_hta: Hoy

Jun 4, 2022 · 7 shares · 1,055 followers View post →

Vicente Pallares

@vic_pallares · X

RT @gt_hta: Hoy

Jun 4, 2022 · 7 shares · 5,424 followers View post →

Paco Valls

@pacovr53 · X

RT @gt_hta: Hoy

Jun 3, 2022 · 7 shares · 2,627 followers View post →

NEJM Journal Watch

@JWatch · X

RT @hmkyale: @JWatch I thought this was an imp paper; it estimates benefits of combination therapy in #heartfailure using current data whil…

Jun 3, 2022 · 6 shares · 62,274 followers View post →

Umut Kocabaş

@UmutKocabasMD · X

RT @hmkyale: @JWatch I thought this was an imp paper; it estimates benefits of combination therapy in #heartfailure using current data whil…

Jun 3, 2022 · 6 shares · 1,458 followers View post →

Jonathan Davis, MD, MPHS

@JonathanDavisHF · X

RT @hmkyale: @JWatch I thought this was an imp paper; it estimates benefits of combination therapy in #heartfailure using current data whil…

Jun 3, 2022 · 6 shares · 3,073 followers View post →

Gregg Fonarow MD

@gcfmd · X

RT @hmkyale: @JWatch I thought this was an imp paper; it estimates benefits of combination therapy in #heartfailure using current data whil…

Jun 3, 2022 · 6 shares · 11,826 followers View post →

Muthu Vaduganathan

@mvaduganathan · X

RT @hmkyale: @JWatch I thought this was an imp paper; it estimates benefits of combination therapy in #heartfailure using current data whil…

Jun 3, 2022 · 6 shares · 9,160 followers View post →

Harlan Krumholz

@hmkyale · X

Jun 3, 2022 · 14 likes · 6 shares · 26,516 followers View post →

Encarna Agulló López

@agullo_encarna · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

Jun 2, 2022 · 42 shares · 88 followers View post →

Lorenzo Bertomeu

@BertomeuLorenzo · X

RT @mi_cardiologo: Efecto de la terapia combinada (ARNI+iSLGT2+AMR) en el pronostico de los pacientes con IC según la Fracción de eyección.…

Jun 2, 2022 · 37 shares · 1,409 followers View post →

Roberto Lugo

@RobertoLG86MI · X

RT @mi_cardiologo: Efecto de la terapia combinada (ARNI+iSLGT2+AMR) en el pronostico de los pacientes con IC según la Fracción de eyección.…

Jun 2, 2022 · 37 shares · 54 followers View post →

alicia mabel gimenez

@aliciamabelgim1 · X

RT @LuisZuritaG: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fractio…

Jun 2, 2022 · 1 share · 319 followers View post →

Elisabete

@EAlzolaMA · X

RT @mi_cardiologo: Efecto de la terapia combinada (ARNI+iSLGT2+AMR) en el pronostico de los pacientes con IC según la Fracción de eyección.…

Jun 2, 2022 · 37 shares · 339 followers View post →

Luis Zurita G.

@LuisZuritaG · X

Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction https://t.co/tDwPC9IFs5

Jun 2, 2022 · 1 share · 6,426 followers View post →

ASANO

@ShunASN_circ · X

RT @CircAHA: #ResearchLetter Simpub #HeartFailure2022: Combination Rx (ARNI+MRA+SGLT2i) estimated to have substantial benefits in averting…

Jun 1, 2022 · 39 shares · 3 followers View post →

Raul Villar

@DrRaulvillar · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 31, 2022 · 42 shares · 410 followers View post →

Andrew J Sauer MD

@AndrewJSauer · X

RT @HanCardiomd: Estimating the Benefits of Combination Medical Therapy in #HFmrEF and #HFpEF https://t.co/LWsWvzoXzn #HeartFailure2022 @…

May 31, 2022 · 18 shares · 19,287 followers View post →

Julia Seller

@JuliaSellerm · X

May 31, 2022 · 3 likes · 6,010 followers View post →

Favio varon suarez

@faviomagno777 · X

RT @mi_cardiologo: Efecto de la terapia combinada (ARNI+iSLGT2+AMR) en el pronostico de los pacientes con IC según la Fracción de eyección.…

May 31, 2022 · 37 shares · 87 followers View post →

Ethiopian Society of Cardiac Professionals-ESCP

@SCPEthiopia · X

RT @HanCardiomd: Estimating the Benefits of Combination Medical Therapy in #HFmrEF and #HFpEF https://t.co/LWsWvzoXzn #HeartFailure2022 @…

May 31, 2022 · 18 shares · 415 followers View post →

Ethiopian Society of Cardiac Professionals-ESCP

@SCPEthiopia · X

RT @kamleshkhunti: Really nice modelling by @mvaduganathan et al showing benefits of combination MRA, ARNI, & SGLT2i extend up to LVEF 65%…

May 31, 2022 · 14 shares · 415 followers View post →

Rocío García Vergara

@RocoGarcaVerga1 · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 31, 2022 · 42 shares · 58 followers View post →

Coral Gomez

@CoralGo96637972 · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 31, 2022 · 42 shares · 46 followers View post →

Ignacio G

@IgnacioGLillo · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 31, 2022 · 42 shares · 1,464 followers View post →

Dr.Vaibhav Triapthi MD

@DrVaibhav1992 · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 31, 2022 · 42 shares · 191 followers View post →

Alexandra de Paz

@AlexandradePaz8 · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 31, 2022 · 42 shares · 93 followers View post →

Miguel Turégano

@tureyedro · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 31, 2022 · 42 shares · 811 followers View post →

María

@Drascully · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 31, 2022 · 42 shares · 226 followers View post →

María Jesús V.G.

@Charrachaparra · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 31, 2022 · 42 shares · 171 followers View post →

Sergio Cinza

@SergioCinza · X

RT @mi_cardiologo: Efecto de la terapia combinada (ARNI+iSLGT2+AMR) en el pronostico de los pacientes con IC según la Fracción de eyección.…

May 31, 2022 · 37 shares · 1,709 followers View post →

David Vieito

@vieitoporto · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 31, 2022 · 42 shares · 282 followers View post →

Isabel BLASCO

@iblascog · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 31, 2022 · 42 shares · 385 followers View post →

Fernando rius

@rius232 · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 31, 2022 · 42 shares · 27 followers View post →

Estrella

@DraStars · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 31, 2022 · 42 shares · 162 followers View post →

Salvador Garcia

@Chavaregal90 · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 135 followers View post →

Jorge Vargas

@JorgeVa56642330 · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 95 followers View post →

Gerardo Viveros RGL.

@gerardo_viveros · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 805 followers View post →

CardioEd Bot

@CardioBot · X

RT @Tomas_MA_Cardio: La importancia de la terapia combinada desde un inicio en pacientes con insuficiencia cardíaca con FEVI preservada, el…

May 30, 2022 · 1 share · 1,205 followers View post →

Miguel Azañedo V

@MikeMD2486 · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 403 followers View post →

Manuel Vazquez V

@ManuelVVidaurre · X

RT @mi_cardiologo: Efecto de la terapia combinada (ARNI+iSLGT2+AMR) en el pronostico de los pacientes con IC según la Fracción de eyección.…

May 30, 2022 · 37 shares · 277 followers View post →

Tomás Miranda Aquino

@Tomas_MA_Cardio · X

La importancia de la terapia combinada desde un inicio en pacientes con insuficiencia cardíaca con FEVI preservada, el beneficio es claro hasta una FEVI de 65%. #CardioTwitter #CardioEd @ANCAM_MEXICO @CircAHA https://t.co/Cg3dxJYqiv https://t.co/8Ey9cgfQFQ

May 30, 2022 · 4 likes · 1 share · 701 followers View post →

Salvador Garcia

@Chavaregal90 · X

RT @mi_cardiologo: Efecto de la terapia combinada (ARNI+iSLGT2+AMR) en el pronostico de los pacientes con IC según la Fracción de eyección.…

May 30, 2022 · 37 shares · 135 followers View post →

fausto heredia z.

@drfherediaz · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 4,355 followers View post →

Arturo

@cardiogeriatra · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 596 followers View post →

Dr. Perez-Belmonte

@belmonte_dr · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 149 followers View post →

Valle M.

@LePetitCitron_ · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 1,122 followers View post →

Román Freixa Pamias

@rfreixap · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 1,013 followers View post →

Román Freixa Pamias

@rfreixap · X

RT @mi_cardiologo: Efecto de la terapia combinada (ARNI+iSLGT2+AMR) en el pronostico de los pacientes con IC según la Fracción de eyección.…

May 30, 2022 · 37 shares · 1,013 followers View post →

Alejandro I. Pérez Cabeza

@alejandroipc2 · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 1,164 followers View post →

Juan Carlos Obaya

@jcobaya69 · X

RT @gcfmd: @naderjo BB was included as background therapy for HFrEF as was ACEI For the HFmrEF/HFpEF analyses ARB was background These an…

May 30, 2022 · 4 shares · 857 followers View post →

Pablo J. Sanz Navarro

@PauJosep · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 206 followers View post →

MercheRC

@rc_merche · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 311 followers View post →

Roberto Gutiérrez

@DrRobertoGuti · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 782 followers View post →

RIM

@Ricardoscientia · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 914 followers View post →

Laura Pérez

@tatana2007 · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 237 followers View post →

APICEC

@APICEC1 · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 264 followers View post →

Cardiología Preventiva

@preventiva_SEC · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 2,443 followers View post →

juan lopez

@jd1lopez · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 1,073 followers View post →

Julio

@yulnunezvill · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 4,256 followers View post →

Manuel Barreiro-Perez

@manuelbarreirop · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 1,851 followers View post →

Xtian_ sci hub

@Xtian_tuck · X

RT @mi_cardiologo: Efecto de la terapia combinada (ARNI+iSLGT2+AMR) en el pronostico de los pacientes con IC según la Fracción de eyección.…

May 30, 2022 · 37 shares · 30,493 followers View post →

Juan Quiles

@juanquiles · X

RT @mi_cardiologo: Efecto de la terapia combinada (ARNI+iSLGT2+AMR) en el pronostico de los pacientes con IC según la Fracción de eyección.…

May 30, 2022 · 37 shares · 3,860 followers View post →

Lorenzo Fácila

@mi_cardiologo · X

RT @mi_cardiologo: Efecto de la terapia combinada (ARNI+iSLGT2+AMR) en el pronostico de los pacientes con IC según la Fracción de eyección.…

May 30, 2022 · 37 shares · 7,939 followers View post →

lluissimon

@lluissp · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 232 followers View post →

Pere Llorens

@LlorensPere · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 3,626 followers View post →

Miriam Sandín

@miriamsandin · X

RT @juanquiles: Beneficios de la combinación de sacubitril/valsartan + antialdosterónico + iSGLT2. En el análisis realizado de los estudios…

May 30, 2022 · 42 shares · 3,009 followers View post →

juan ramon

@RamonTasmania · X

RT @gcfmd: @naderjo BB was included as background therapy for HFrEF as was ACEI For the HFmrEF/HFpEF analyses ARB was background These an…

May 30, 2022 · 4 shares · 94 followers View post →

Dr Anastasia Mihailidou FAHA FCSANZ FESC

@AnastasiaSMihai · X

RT @BhallaResearch: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Frac…

May 30, 2022 · 1 share · 19,295 followers View post →

Laboratory of Vivek Bhalla, MD- Stanford

@BhallaResearch · X

Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction | Circulation https://t.co/4QW2sXcZRs

May 30, 2022 · 3 likes · 1 share · 1,658 followers View post →

Akihiro Nomura

@akihiro_nomuryn · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 29, 2022 · 24 shares · 1,899 followers View post →

Jonathan Davis, MD, MPHS

@JonathanDavisHF · X

RT @gcfmd: @naderjo BB was included as background therapy for HFrEF as was ACEI For the HFmrEF/HFpEF analyses ARB was background These an…

May 29, 2022 · 4 shares · 3,073 followers View post →

Carlos Fernandez, PharmD

@rojasfec · X

RT @gcfmd: @naderjo BB was included as background therapy for HFrEF as was ACEI For the HFmrEF/HFpEF analyses ARB was background These an…

May 29, 2022 · 4 shares · 617 followers View post →

Gregg Fonarow MD

@gcfmd · X

@naderjo BB was included as background therapy for HFrEF as was ACEI For the HFmrEF/HFpEF analyses ARB was background These analyses were of the incremental benefits of ARNI+MRA+SGLT2i https://t.co/WkCB5IFioa https://t.co/lnXwR2jRsR @mvaduganathan

May 29, 2022 · 12 likes · 4 shares · 11,826 followers View post →

Sherif

@Sherifdotcom · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 28, 2022 · 24 shares · 132 followers View post →

Martin Cadeiras

@mcadeiras · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 27, 2022 · 24 shares · 256 followers View post →

Lorenzo Bertomeu

@BertomeuLorenzo · X

RT @JoseJuanatey: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fracti…

May 26, 2022 · 2 shares · 1,409 followers View post →

Jose Manuel Lema

@josemanuellema · X

RT @JoseJuanatey: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fracti…

May 26, 2022 · 2 shares · 844 followers View post →

José R. Juanatey

@JoseJuanatey · X

Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction | tan solo generador de hipótesis! De otra forma desincentiva la investigación! ⁦@secardiologia⁩ ⁦@cardiologiaCHUS⁩ https://t.co/epc53d8sn0

May 26, 2022 · 2 likes · 2 shares · 13,758 followers View post →

Stefania Arciello

@StefaniaArciell · X

Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction https://t.co/Di4xvGFGae

May 24, 2022 · 3 likes · 1,941 followers View post →

Miguel Turégano

@tureyedro · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 24, 2022 · 24 shares · 811 followers View post →

Elisabete

@EAlzolaMA · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 24, 2022 · 24 shares · 339 followers View post →

juan lopez

@jd1lopez · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 24, 2022 · 24 shares · 1,073 followers View post →

Dr. Luiz Silva

@DrLuizSilva1 · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 24 shares · 390 followers View post →

Ana Karyn Ehrenfried de Freitas

@ana_ehrenfried · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 24 shares · 62 followers View post →

Ankit Bhatia, MD

@AKBhatiaMD · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 24 shares · 623 followers View post →

Laura_Jordan

@laura_jordanm · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 24 shares · 78 followers View post →

Salim S. Hayek, MD

@salimhayek · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 24 shares · 3,806 followers View post →

Darth Kiki

@enriquegnzz · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 24 shares · 468 followers View post →

C.K.

@firesigh · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 24 shares · 16 followers View post →

juan ramon

@RamonTasmania · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 24 shares · 94 followers View post →

CardioAcademic

@CardioAcademic · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 24 shares · 3,220 followers View post →

Nikhil Narang, MD

@Nikhil15 · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 24 shares · 3,057 followers View post →

Javed Butler

@JavedButler1 · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 24 shares · 6,595 followers View post →

Andreas Gevaert

@AndreasGevaert · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 24 shares · 4,707 followers View post →

Alejandro Mariño

@marinoalejo · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 24 shares · 469 followers View post →

Mark Belkin

@MarkBelkinMD · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 24 shares · 2,448 followers View post →

Victoria Delgado

@VDelgadoGarcia · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 24 shares · 11,715 followers View post →

Shelley Zieroth

@ShelleyZieroth · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 24 shares · 9,999 followers View post →

Jan Verwerft

@VerwerftJan · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 24 shares · 4,229 followers View post →

juan lopez

@jd1lopez · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 2 shares · 1,073 followers View post →

Muthu Vaduganathan

@mvaduganathan · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 24 shares · 9,160 followers View post →

Gregg Fonarow MD

@gcfmd · X

May 23, 2022 · 51 likes · 24 shares · 11,826 followers View post →

Muthu Vaduganathan

@mvaduganathan · X

RT @gcfmd: Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction http…

May 23, 2022 · 2 shares · 9,160 followers View post →

Gregg Fonarow MD

@gcfmd · X

Estimating the Benefits of Combination Medical Therapy in Heart Failure with Mildly Reduced and Preserved Ejection Fraction https://t.co/yOkcbBNdvg @CircAHA @mvaduganathan @scottdsolomon @escardio https://t.co/7S05o2vTN1

May 23, 2022 · 10 likes · 2 shares · 11,826 followers View post →

Estimating the Benefits of Combination Medical Therapy in Heart Failure With Mildly Reduced and Preserved Ejection Fraction.

Mentions per month

Where it's discussed

What people are saying

Abstract in brief

Top posts

All mentions

2022 Guidelines for Managing Heart Failure with Preserved Ejection Fraction

2022 Guidelines for Heart Failure Management Explained